A Predictive Model for Aggressive Non-Hodgkin's Lymphoma

Abstract

The international index and the age-adjusted international index should be used in the design of future therapeutic trials in patients with aggressive non-Hodgkin's lymphoma and in the selection of appropriate therapeutic approaches for individual patients.